title: Occult infection of peripheral B cells by hepatitis C variants which have low translational efficiency in cultured hepatocytes.
abstract: BACKGROUND
  Plasma hepatitis C virus (HCV) originates from hepatocytes. However, in certain subjects, B cells may harbour both plasma strains and occult HCV strains tha t are not detected in the plasma. The internal ribosome entry site (IRES) of these latter strains is mutated, suggesting that the efficiency of viral translation could drive the cellular tropism of HCV.
  
  
  OBJECTIVE
  To determine if the translational efficiency of IRES variants in cultured hepatocytes or B cells is correlated with their cellular tropism in vivo.
  
  
  METHODS
  The efficiency of IRES of 10 B cell-specific variants and nine plasma variants, isolated from six patients with compartmentalised variants in B cells, was estimated by bicistronic dual luciferase expression in hepatocyte cell types (Huh7), in primary cultured human hepatocytes (PCHs) and in two B cell lines (Raji and Daudi).
  
  
  RESULTS
  For each of the six subjects, the plasma IRESes were significantly and repeatedly more efficient than B cell IRESes in Huh7 (1.7+/-0.3 vs 0.7+/-0.2; p<0.01) and PCH cells. In B cell lines, B cell and plasma IRES had similar low efficiencies (0.8+/-0.1 vs 0.9+/-0.1; NS). For three subjects, two IRES variants from the same compartment could be analysed, and had the same efficiency in each cell type. Silencing the lupus antigen, a known IRES trans-acting factor, inhibited plasma IRES variants to a greater extent than B cell-specific IRESes.
  
  
  CONCLUSIONS
  B cells can harbour occult variants that have a poor translational efficiency in hepatocytes, strongly suggesting their extra-hepatic origin and raising the hypothesis that competition between HCV variants with different IRESes is driven at a translational level in hepatic, as well as in extra-hepatic, sites.
authors.affiliation: INSERM U948, Hôtel-Dieu, 9 quai Moncousu, Nantes, France.
authors.forename: Tony
authors.initials: T
authors.lastname: Durand
authors.forename: Gaëtana
authors.initials: G
authors.lastname: Di Liberto
authors.forename: Hélène
authors.initials: H
authors.lastname: Colman
authors.forename: Anne
authors.initials: A
authors.lastname: Cammas
authors.forename: Sebastien
authors.initials: S
authors.lastname: Boni
authors.forename: Patrick
authors.initials: P
authors.lastname: Marcellin
authors.forename: Annie
authors.initials: A
authors.lastname: Cahour
authors.forename: Stephan
authors.initials: S
authors.lastname: Vagner
authors.forename: Cyrille
authors.initials: C
authors.lastname: Féray
mesh_terms: D000328:Adult; D001402:B-Lymphocytes / Q000821:virology*; D001483:Base Sequence; D002478:Cells, Cultured; D005260:Female; D016174:Hepacivirus / Q000235:genetics* / Q000302:isolation & purification / Q000502:physiology; D019698:Hepatitis C, Chronic / Q000821:virology*; D022781:Hepatocytes / Q000821:virology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010802:Phylogeny; D014176:Protein Biosynthesis; D016415:Sequence Alignment; D014407:Tumor Cells, Cultured; D019562:Viral Load; D056189:Viral Tropism / Q000235:genetics; D014779:Virus Replication / Q000235:genetics